ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,661 | +7.6% | 14,947 | +42.9% | 0.00% | – |
| Q1 2023 | $376,945 | -92.6% | 10,462 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $5,083,050 | -14.2% | 128,619 | -12.7% | 0.01% | -25.0% |
| Q3 2022 | $5,921,000 | -54.9% | 147,370 | -52.8% | 0.01% | -50.0% |
| Q2 2022 | $13,121,000 | +8.7% | 312,118 | +0.7% | 0.02% | +33.3% |
| Q1 2022 | $12,073,000 | -38.5% | 309,882 | -37.1% | 0.01% | -36.8% |
| Q4 2021 | $19,638,000 | +19.5% | 492,794 | +8.3% | 0.02% | +5.6% |
| Q3 2021 | $16,440,000 | -17.6% | 454,894 | -6.6% | 0.02% | -18.2% |
| Q2 2021 | $19,963,000 | -15.2% | 487,022 | -9.8% | 0.02% | -24.1% |
| Q1 2021 | $23,551,000 | -22.5% | 539,906 | -11.1% | 0.03% | -27.5% |
| Q4 2020 | $30,386,000 | – | 607,115 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |